Myomo Receives Technology License Fee Payment from China Joint Venture Company
Payment of $1.7 million permits the start of activities to manufacture and sell the MyoPro® in China BOSTON (April 10, 2023) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces receipt of the final portion […]
Myomo Makes NYSE American Section 610(b) Public Announcement
BOSTON (March 15, 2023) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2022 filed on March 13, […]
Myomo Reports Fourth Quarter and Full Year 2022 Financial Results
Fourth quarter revenue was $4.0 million, up 2% sequentially 387 patients added to the pipeline in fourth quarter, up 75% compared with Q4 2021 Conference call begins at 10:00 a.m. Eastern time today BOSTON (March 13, 2023) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased […]
Myomo to Report Fourth Quarter Financial Results on March 13, 2023
BOSTON (March 6, 2023) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months and year ended December 31, 2022 on March 13, 2023 before […]
Myomo To Participate in the 35th Annual Roth Conference
BOSTON (March 6, 2023) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that management will presenting at the 35th Annual Roth Conference, March 13-14, 2023 at The Ritz-Carlton, Dana Point, Calif. David Henry, Myomo’s […]
MyoPro Approved in Australia by National Disability Insurance Scheme
First reimbursement leads to greater access for patients BOSTON (February 6, 2023) ─ Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that for the first time, the National Disability Insurance Scheme (NDIS) in Australia approved a MyoPro […]
Myomo Appoints Yitzchak Jacobovitz to its Board of Directors
BOSTON (January 30, 2023) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting […]
Myomo Announces Closing of $6.5 Million Upsized Public Offering
BOSTON, January 17, 2023 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the closing of its previously announced “best efforts” public offering of 20,000,000 shares of common stock (or common stock equivalents in […]
Myomo Announces Pricing of $6.5 Million Upsized Public Offering
BOSTON, January 12, 2023 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the pricing of its “best efforts” public offering of 20,000,000 shares of common stock (or common stock equivalents in lieu thereof) […]
Myomo Announces Initiative to Reduce Cash Burn
Undertakes a reduction in force to enhance efficiency in its direct billing channel BOSTON, January 10, 2023 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced a reduction in force for the purpose of […]